Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro - Wikidata - wikimedia - TriplyDB

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

http://www.wikidata.org/entity/Q27473519

about

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action MAIT cells are activated during human viral infections Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease Synergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus Replication Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes CD81 is an entry coreceptor for hepatitis C virus CD81 is required for hepatitis C virus glycoprotein-mediated viral infection Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogens Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?Therapeutic implications of hepatitis C virus resistance to antiviral drugs.Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.Hepatitis C drug discovery: in vitro and in vivo systems and drugs in the pipeline.A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutation.Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.Hepatitis C virus infection: in vivo and in vitro models.Primary hepatocytes as targets for hepatitis C virus replication.L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.Advances and challenges in studying hepatitis C virus in its native environment.Heme and HO-1 Inhibition of HCV, HBV, and HIV.Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells.Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication.Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.Inhibition of HCV by the serpin antithrombin III Secretion of functional plasma haemostasis proteins in long-term primary cultures of human hepatocytes.Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection?

P2860

Q24301056-35F545FF-3293-4B0E-9278-D78E6E40A36A Q24519072-C6D05973-9D7F-4542-9BF3-7E151DE4496E Q24530717-067B98B6-B6F0-4E69-9526-369335189756 Q24672548-14C1208E-0D86-4823-9B7A-FCBA317DD5C9 Q27469032-B80E5DDC-477E-46AB-8A38-96AA2DC3C7E9 Q27472970-E6329A12-D11C-4A95-926A-2F0739A818C0 Q27473126-B0092742-1AD8-47D7-BF4F-6D40A41CD0D8 Q27477551-A1B98E69-9BAB-43A2-95B6-AEB3AE6F5D22 Q27485298-55E9F9D5-9244-4CF6-8E4E-3E85F9BBEE9D Q27488358-5A3A18EF-32E0-413B-A0AA-C81660E54E20 Q29614812-F332A556-8445-4BF2-8429-684EC3E8D199 Q29619745-60F2B54D-44EB-4D09-B370-BE52C94A2EDC Q33877539-4785C653-5641-4D62-9273-22659A995063 Q34319249-451EE51F-2593-4552-8FD1-2CBDA72A213C Q34358742-4BA91DE1-91D5-4243-A741-93F52DE237C1 Q34409020-23AE1C92-1E05-4D0F-8613-775FF450B148 Q34572554-7B78CA08-E323-4B07-8E99-0799E4229628 Q35011152-71C13ECA-199F-42DB-94E2-1F5F19D8E0CE Q35033949-234F7EA6-6771-49EC-8865-6EB963D73834 Q35917417-5429CA3D-47D4-4ECF-BBDA-548578A4E5CF Q36590856-DB8A8CA7-C6CD-4936-B658-757267B76160 Q36933791-4D4A84A6-B3C6-4CE2-B95D-51034FFBBB60 Q36980739-355419A2-2C47-47AC-ACD0-EC340AF4921F Q37352203-6A52967F-A636-470F-A98D-74480E31DE53 Q37557428-6D49AC1A-FF8C-490F-8D34-46F38E44A348 Q37604941-96AF3FAA-1B22-43C2-9D45-23AC66C7B486 Q37798816-11BD5F23-6899-4FC9-A84D-270386DEA4A2 Q38051629-5744E3DB-6322-4F8C-9D4C-4F75D30AFDEF Q38352468-E769EE5B-8781-4EEF-805F-D5055E2269E2 Q39072381-39260E4E-36EF-4F8C-BC17-6F55242D33AB Q39092410-7F62EC2C-AE99-45C0-A0D2-88937EF174A4 Q39791492-25854DC5-C812-4715-9014-5E5A01BCF806 Q40346674-891051E6-87F1-47F5-BABA-5F301BDFF60E Q41531461-CA456056-1C8F-4BA2-ACF2-F1FD7755B91F Q42406960-36584B4B-875D-4177-9F9B-ADD81B464451 Q47594150-FF68EA17-7F85-48A7-96CC-E18AD63C918F Q50569910-9A565BB9-5E4B-4161-B828-B4BD9B96300A

P2860

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

http://www.wikidata.org/entity/Q27473519

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@ast

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@en

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@nl

type

label

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@ast

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@en

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@nl

prefLabel

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@ast

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@en

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@nl

P1433

Q27473519-14737E7C-3398-41FA-B2F9-F3F0CD691A87

P1476

Q27473519-9E71C58C-DD47-40FC-AF78-AA69A1CB3C91

P2093

Q27473519-1E043879-F1C6-4F67-9FD6-7E933C7621DB

Q27473519-63010376-4DDA-4B49-A12C-07136DD3AC49

Q27473519-82B6974E-1D07-41AD-B36C-D7E7FDBB6745

Q27473519-8326C93F-E910-48C1-8E4F-16C9C69BB39B

Q27473519-8A392D08-87EF-471F-91C6-12FA0EA45063

Q27473519-B99B34A2-E64D-4C8C-8FEF-C5FAB2254CC7

Q27473519-D4DF30E0-D359-47DC-AD00-6815E35BE3C1

Q27473519-DACDD275-6122-4073-AD9D-E731C49E5B41

P2860

Q27473519-0FF5C40F-2F20-4363-BF63-EAABB1EBDF87

Q27473519-1B5F5EE3-CF84-44F2-953B-52CC967165E9

Q27473519-210CBF73-9BE8-40BC-B464-E1FF376D5E13

Q27473519-22ED697C-E433-4812-9495-D643C919CA18

Q27473519-246367AD-EB47-42F8-81C7-7F933976A0A0

Q27473519-329E5E1C-D562-4183-B64A-AF54D117E364

Q27473519-389D2C85-AAD6-40AE-9873-0D4670588DE5

Q27473519-3A8924EC-2CBD-40A3-A6B4-873B269D2098

Q27473519-3D42C148-820E-4E33-8DDF-30446D94909A

Q27473519-3DED844F-AD5C-41B0-B643-AE540AFD908B

P304

Q27473519-C6F5D37F-2DE6-43C9-BA38-1C2BCF695B07

P31

Q27473519-952AFA00-2EC5-4C8A-A263-2191A9F27990

P3181

Q27473519-44A99028-F450-47F6-A13E-6735E7F48257

P356

Q27473519-A4DED5BB-A263-4DB5-8457-6FD5D88CF2E4

P433

Q27473519-59241E38-8C9E-41FD-BF0C-3E15A4170007

P478

Q27473519-D1A258FB-DDC8-4483-ACB4-F36666F7166E

P50

Q27473519-42C36D15-883B-4F0A-AB6A-D70EDAA86B3D

Q27473519-5CDAA890-01A0-4EFE-AB3F-FC81681308EE

P577

Q27473519-ED7690DB-9858-4C68-802B-5F2E6DA825A8

P698

Q27473519-B3EDC8A3-98F0-41C9-92B3-58F5AACBE6C7

P921

Q27473519-4F4354B1-763B-4FF0-8D1A-A1D2E4497835

P932

Q27473519-75CA6FE0-0A75-4836-90A8-DAE9F016A9FD

P3181

P356

JVI.76.16.8189-8199.2002

P1433

Journal of Virology

P1476

Alpha Interferon Inhibits Hepa ...... Hepatocytes Infected In Vitro

@en

P2093

Alexandre Soulier

http://www.w3.org/2001/XMLSchema#string

Chantal Fournier

http://www.w3.org/2001/XMLSchema#string

Daniel Dhumeaux

http://www.w3.org/2001/XMLSchema#string

Dominique Larrey

http://www.w3.org/2001/XMLSchema#string

Joliette Coste

http://www.w3.org/2001/XMLSchema#string

Patrick Maurel

http://www.w3.org/2001/XMLSchema#string

Rozenn Brillet

http://www.w3.org/2001/XMLSchema#string

Valérie Castet

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

The human interferon alpha/beta receptor: characterization and molecular cloning

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Effect of alpha interferon on the hepatitis C virus replicon

Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay

P304

8189-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

554241

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.76.16.8189-8199.2002

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Pawlotsky

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12134024

http://www.w3.org/2001/XMLSchema#string

P921

P932

155162

http://www.w3.org/2001/XMLSchema#string